Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy

James Liu, Amanda M. Murray, Erin B. Mankus, Kayla E. Ireland, Ometeotl Acosta, Patrick S. Ramsey

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Intrahepatic cholestasis of pregnancy is an incompletely understood disease that poses significant fetal risks, including stillbirth. Treatment of intrahepatic cholestasis of pregnancy is aimed at relieving maternal symptoms and improving fetal outcomes. CASE: A 21-year-old gravid woman, 3 para 0111, presented at 27 2/7 weeks of gestation with severe intrahepatic cholestasis of pregnancy. Her clinical course was refractory to first-line therapy with ursodiol, and she was started on rifampin with rapid improvement of symptoms and transaminitis. Despite maternal improvement, she was delivered at 31 weeks of gestation for persistent nonreassuring fetal status. CONCLUSION: Rifampin may be an effective adjunctive therapy for intrahepatic cholestasis of pregnancy refractory to ursodiol alone. Additional research is needed to assess short-term and long-term maternal and newborn outcomes, because fetal deterioration still occurred in spite of maternal improvement.

LanguageEnglish (US)
Pages678-681
Number of pages4
JournalObstetrics and gynecology
Volume132
Issue number3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Rifampin
Mothers
Ursodeoxycholic Acid
Pregnancy
Fetal Distress
Stillbirth
Therapeutics
Newborn Infant
Intrahepatic Cholestasis of Pregnancy
Research

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy. / Liu, James; Murray, Amanda M.; Mankus, Erin B.; Ireland, Kayla E.; Acosta, Ometeotl; Ramsey, Patrick S.

In: Obstetrics and gynecology, Vol. 132, No. 3, 01.01.2018, p. 678-681.

Research output: Contribution to journalArticle

Liu, James ; Murray, Amanda M. ; Mankus, Erin B. ; Ireland, Kayla E. ; Acosta, Ometeotl ; Ramsey, Patrick S. / Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy. In: Obstetrics and gynecology. 2018 ; Vol. 132, No. 3. pp. 678-681.
@article{5deec481b36545c794c474092b9cf520,
title = "Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy",
abstract = "BACKGROUND: Intrahepatic cholestasis of pregnancy is an incompletely understood disease that poses significant fetal risks, including stillbirth. Treatment of intrahepatic cholestasis of pregnancy is aimed at relieving maternal symptoms and improving fetal outcomes. CASE: A 21-year-old gravid woman, 3 para 0111, presented at 27 2/7 weeks of gestation with severe intrahepatic cholestasis of pregnancy. Her clinical course was refractory to first-line therapy with ursodiol, and she was started on rifampin with rapid improvement of symptoms and transaminitis. Despite maternal improvement, she was delivered at 31 weeks of gestation for persistent nonreassuring fetal status. CONCLUSION: Rifampin may be an effective adjunctive therapy for intrahepatic cholestasis of pregnancy refractory to ursodiol alone. Additional research is needed to assess short-term and long-term maternal and newborn outcomes, because fetal deterioration still occurred in spite of maternal improvement.",
author = "James Liu and Murray, {Amanda M.} and Mankus, {Erin B.} and Ireland, {Kayla E.} and Ometeotl Acosta and Ramsey, {Patrick S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/AOG.0000000000002794",
language = "English (US)",
volume = "132",
pages = "678--681",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Adjuvant use of rifampin for refractory intrahepatic cholestasis of pregnancy

AU - Liu, James

AU - Murray, Amanda M.

AU - Mankus, Erin B.

AU - Ireland, Kayla E.

AU - Acosta, Ometeotl

AU - Ramsey, Patrick S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - BACKGROUND: Intrahepatic cholestasis of pregnancy is an incompletely understood disease that poses significant fetal risks, including stillbirth. Treatment of intrahepatic cholestasis of pregnancy is aimed at relieving maternal symptoms and improving fetal outcomes. CASE: A 21-year-old gravid woman, 3 para 0111, presented at 27 2/7 weeks of gestation with severe intrahepatic cholestasis of pregnancy. Her clinical course was refractory to first-line therapy with ursodiol, and she was started on rifampin with rapid improvement of symptoms and transaminitis. Despite maternal improvement, she was delivered at 31 weeks of gestation for persistent nonreassuring fetal status. CONCLUSION: Rifampin may be an effective adjunctive therapy for intrahepatic cholestasis of pregnancy refractory to ursodiol alone. Additional research is needed to assess short-term and long-term maternal and newborn outcomes, because fetal deterioration still occurred in spite of maternal improvement.

AB - BACKGROUND: Intrahepatic cholestasis of pregnancy is an incompletely understood disease that poses significant fetal risks, including stillbirth. Treatment of intrahepatic cholestasis of pregnancy is aimed at relieving maternal symptoms and improving fetal outcomes. CASE: A 21-year-old gravid woman, 3 para 0111, presented at 27 2/7 weeks of gestation with severe intrahepatic cholestasis of pregnancy. Her clinical course was refractory to first-line therapy with ursodiol, and she was started on rifampin with rapid improvement of symptoms and transaminitis. Despite maternal improvement, she was delivered at 31 weeks of gestation for persistent nonreassuring fetal status. CONCLUSION: Rifampin may be an effective adjunctive therapy for intrahepatic cholestasis of pregnancy refractory to ursodiol alone. Additional research is needed to assess short-term and long-term maternal and newborn outcomes, because fetal deterioration still occurred in spite of maternal improvement.

UR - http://www.scopus.com/inward/record.url?scp=85056403876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056403876&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000002794

DO - 10.1097/AOG.0000000000002794

M3 - Article

VL - 132

SP - 678

EP - 681

JO - Obstetrics and Gynecology

T2 - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -